Magnetic Resonance Angiography Clinical Trial
Official title:
An Open, Contrast-Enhanced Magnetic Resonance Angiography (CE-MRA) Study of Arteries Using Gadovist 1.0 in Comparison to Intra-Arterial Digital Subtraction Angiography (IA DSA) Using Ultravist
This trial is to show the diagnostic efficacy of Gadovist for contrast enhanced magnetic resonance angiography (CE-MRA) of the arteries.
This trial is to show the diagnostic efficacy of Gadovist for contrast enhanced Magnetic Resonance Angiography (CE-MRA) of arteries (specified vessel segments) by analyzing the rate of agreement, image quality, and diagnostic confidence between a CE-MRA based diagnosis and the diagnosis achieved from the comparator procedure IA DSA using Ultravist. ;
Allocation: Non-Randomized, Intervention Model: Crossover Assignment, Masking: Open Label, Primary Purpose: Diagnostic
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT03768999 -
Comparison of Magnetic Resonance Coronary Angiography (MRCA) With Coronary Computed Tomography Angiography (CTA)
|
||
Completed |
NCT04189068 -
Fatal Cerebral Infarction After Nasal Augmentation With Hyaluronic Acid
|
||
Completed |
NCT02155218 -
Improving the Concentration of MR Contrast in the Arteries
|
N/A | |
Completed |
NCT01095081 -
GARDIAN, Gadovist in Routine Diagnostic Magnetic Resonance Imaging Administration in Non-selected Patients
|
N/A | |
Completed |
NCT00652418 -
Magnevist (SH L 451A) Intra-individual Dose Comparison Study in Magnetic Resonance Angiography
|
Phase 2 | |
Recruiting |
NCT03117218 -
Correlation Between Quantitative Analysis of Coronary MRA and FFR
|
N/A | |
Completed |
NCT02997046 -
Ferumoxytol Enhanced Magnetic Resonance Angiography in Chronic Kidney Disease
|
||
Completed |
NCT04312711 -
3D Time-of-Flight Magnetic Resonance Angiography in Hemodialysis Patients With Arteriovenous Fistula
|
N/A |